Biopharma royalty and drug-platform company
2 listed classes/securities ($LGND, $LGNDZ) are filed under this issuer; the holder table aggregates all of them.
| Ticker | Title of class | CUSIP | Sector | Filers | Value |
|---|---|---|---|---|---|
| unmapped | NOTE 0.750%10/0 | 53220KAH1 | — | 1 | $36,089,554 |
| $LGND NASDAQ | COM NEW | 53220K504 | health | 2 | $8,047,588 |
| $LGNDZ NASDAQ | COM | 53220K215 | health | 1 | $20 |
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 75 | New buy | 21,500,000 | $36,089,554 | 0.0% |
| Bridgewater | 55 | New buy | 9,763 | $3,049,668 | 0.0% |
| Steve Cohen / Point72 | 75 | Added +1900% | 16,000 | $4,997,920 | 0.0% |
| Ancora | 42 | Holds (flat) | 12,000 | $20 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.